Aurora Kinase Inhibitors in Head and Neck Cancer

Guangying Qi1, Jing Liu1, Sisi Mi1

  • 1Department of Pathology and Physiopathology, Hepatobiliary Surgery, Affiliated Hospital of Guilin Medical University, 541000, China.

Insights

Aurora kinases regulate cell division and are key targets in cancer therapy. New research explores Aurora kinase inhibitors, especially combined with chemotherapy, for improved cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Aurora kinases are serine/threonine kinases crucial for regulating cell division (mitosis).
  • Growing evidence highlights the significant role of Aurora kinases in the development and progression of various cancers (tumorigenesis).

Purpose of the Study:

  • To review recent research on Aurora kinases, focusing on their biological functions.
  • To examine the link between Aurora kinases and tumor progression.
  • To summarize the development and therapeutic potential of Aurora kinase inhibitors.

Main Methods:

  • Literature review of recent studies on Aurora kinases and their inhibitors.
  • Analysis of research data on Aurora kinase biological functions.
  • Examination of studies investigating the role of Aurora kinases in tumorigenesis.

Main Results:

  • Aurora kinases are increasingly recognized as critical regulators in cancer development.
  • Small-molecule inhibitors targeting Aurora kinases show promise as anti-cancer agents.
  • Combination therapy using Aurora kinase inhibitors and chemotherapy is a developing area.

Conclusions:

  • Aurora kinases represent a significant therapeutic target for novel cancer treatments.
  • The development of Aurora kinase inhibitors offers a promising avenue for oncology drug discovery.
  • Further research into combination therapies holds potential for enhancing cancer treatment efficacy.

Related Concept Videos

Arteries of the Head and Neck01:26

Arteries of the Head and Neck

The human body's intricate network of arteries ensures that every organ system receives the necessary oxygen and nutrients for optimal function. The arterial network in the head and neck region is particularly complex, providing vital blood flow to the brain, eyes, and other critical structures. Prominent arteries in this region include the internal carotid arteries and the vertebral arteries.
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
3.7K
Veins of Head and Neck01:19

Veins of Head and Neck

The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
5.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
563
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K